Nasdaq Markets

After hitting (mostly) all the wrong notes last week ECB President Lagarde over the weekend https://www.ecb.europa.eu/press/key/date/2020/html/ecb.sp200913~18360b36e5.en.html adopted a lot of the themes from ECB Chief Economist Lane's blog from Friday.

Investing in 2020 should really come with a disclaimer. The past six-plus months have been one of the most volatile periods on record, with the benchmark S&P 500 losing 34% of its value in less than five weeks, then regaining everything that was lost (and some) in the subseq

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) announced Monday that the European Medicines Agency or EMA has validated a Type II Variation Marketing Authorization Application or MAA for the expanded indication of KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in combination with iv

(RTTNews) - Walmart said it is in deal with drone delivery company Zipline, to launch the "first-of-its-kind drone delivery operation in the U.S." to make on-demand delivery.

Lam Research Corporation LRCX has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at LRCX given that, according to its RSI reading of 29.98, it is now

Laredo Petroleum, Inc. LPI has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at LPI given that, according to its RSI reading of 29.98, it is now in o

HighPoint Resources Corporation HPR has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at HPR given that, according to its RSI reading of 29.43, it is

Electromed, Inc. ELMD has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at ELMD given that, according to its RSI reading of 27.12, it is now in overs

(RTTNews) - Asian stocks closed higher on Monday amid renewed optimism surrounding coronavirus vaccines after drug maker AstraZeneca said that the late-stage clinical trial of its coronavirus vaccine has resumed in the UK. The trial was suspended last week over safety concerns.

HONG KONG (Reuters Breakingviews) - Nvidia has played a risky opening chess move. The U.S. listed graphics-chip specialist led by Jensen Huang will buy UK chip designer Arm from SoftBank and its Vision Fund in a deal worth up to $40 billion. But Arm's customers and regul

The most striking feature has been the way in which market bets on negative rates have diverged between the BoE and Fed.

(RTTNews) - British drug major AstraZeneca, which had halted the trial of coronavirus vaccine AZD1222 last week, has resumed the trial in the U.K, while it is still not certain when the company will start its US trial again.

(RTTNews) - Infosys (INFY), on Monday, said it agreed to acquire GuideVision, one of the largest ServiceNow Elite Partners in Europe. GuideVision is an enterprise service management consultancy specialised in offering strategic advisory, consulting, implementations, training and

(RTTNews) - Vodafone Group Plc (VOD, VOD.L) Monday said it continues to talk with Saudi Telecom Co. regarding the potential sale of its 55% stake in Vodafone Egypt, despite the expiry of the Memorandum of Understanding.

HONG KONG (Reuters Breakingviews) - Nvidia has played a risky opening chess move. The U.S. listed graphics-chip specialist led by Jensen Huang will buy UK chip designer Arm from SoftBank and its Vision Fund in a deal worth up to $40 billion. But Arm's customers and regul

(RTTNews) - CLS Holdings (CLI.L), on Monday, announced that it has unconditionally exchanged contracts to buy three office properties in Greater London and the South East, for £59.71 million, excluding costs, from Aviva Investors.

(RTTNews) - Swiss drug major Novartis (NVS) Monday announced positive topline results from the first Phase III trial of Beovu versus aflibercept in patients with diabetic macular edema or DME.

(RTTNews) - Shares of Checkpoint Therapeutics Inc. (CKPT), which recently touched a 52-week high of $3.83, have gained more than 90 percent so far this year and trade around $3.

(RTTNews) - Euronext (ENXB.BE, ENX.BR, ENX.AS, ENX.PA) Monday confirmed that it has submitted a non-binding offer to London Stock Exchange Group plc to acquire Borsa Italiana.

(RTTNews) - Evotec SE (EVTCY.PK, EVOTF.PK), on Monday, announced that it has entered into a partnership with the French-based BIOASTER Technological Research Institute to advance research for infectious diseases.